Oseltamivir Phosphate
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Preferred Pharmaceuticals, Inc. | repackager | 2 | SUPPLYING |
| Alembic Pharmaceuticals Limited | generic | 2 | SUPPLYING |
| Ajanta Pharma USA Inc. | unknown | 1 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 1 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | repackager | 1 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | generic | 1 | SUPPLYING |
| AvKARE | relabeler | 1 | SUPPLYING |
| Cipla USA Inc. | generic | 1 | SUPPLYING |
| Exelan Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Impurities/Degradation Specifications: Out-of-specification test results. — Recalling firm: Amneal Pharmaceuticals of New York, LLC — Nationwide in the USA
